Developability / manufacturability of bispecifics
23 Jun 2025
Bi/Multispecifics
- How do the structural formats of bispecific antibodies impact their stability, expression levels, and manufacturability?
- What are the common developability challenges faced during the production of bispecifics, such as aggregation, mispairing, or immunogenicity?
- In what ways can early-stage developability assessments guide the selection and engineering of bispecific candidates?
- How do production platforms and purification strategies influence the scalability and quality of bispecific antibody manufacturing?
Industry Expert
